BFlow provides microfluidic devices for preclinical drug validation by laboratories and pharmaceutical companies. These devices allow a better discrimination of molecules with a probable in vivo activity, with the consequent saving in time to the market of the molecule and experimental costs.
BFlow focuses its development line on two lines, on one hand, custom designed microfluidic devices and circular section, and on the other hand, complete organ-on-a-chip solutions tailored to the customer’s needs, which include: microfluidic device, flow dynamics simulation and cell culture instructions to optimize pre-clinical studies.
The financial need is around 170k euros, this will allow the development group to develop:
Do you want to appear on the platform? If you are part of the biotechnological sector of the Euroregion Galicia – North of Portugal, sign up!